During the Sixth Annual Basser Center Scientific Symposium, the 2017 Basser Global Prize was presented to Ashok Venkitaraman, MBBS, PhD, the Ursula Zoellner Professor of Cancer Research and director of the Medical Research Council (MRC) Cancer Unit at the University of Cambridge.

Susan Domchek, MD, discussed recent advancements in BRCA-related research. Dr. Domchek is the Basser Center's Executive Director, Basser Professor in Oncology at the University of Pennsylvania, and Director of the Marianne and Robert MacDonald Cancer Risk Evaluation Center.

Good Morning Football features 99-year old Eagles fan, Phil Basser, father of Basser Center co-founder Mindy Gray. 

Phil Basser, inspiring father of Basser Center co-founder Mindy Gray, made it onto Fox News for his legendary love of the Philadelphia Eagles!

The Basser Center's #invisiblegenes social media campaign is spreading awareness about hereditary cancers. During this campaign, we will celebrate the genes we know we share with our families, while encouraging people to explore the invisible genes as well, like BRCA gene mutations that can increase risk for developing certain types of cancer.

WNBC's Dave Price took a break from weather casting to help us raise awareness about hereditary cancer! Reveal your #INVISIBLEGENES and share this video with family and friends to help us raise awareness about hereditary cancers.

The Basser Center for BRCA's Executive Director, Susan Domchel, MD, sheds some light on BRCA mutations and hereditary cancer.

Men and women with BRCA gene mutations are at heightened risk for developing certain cancers, including breast, ovarian, prostate, and pancreatic cancers. Learn more at Basser.org.

2016 Basser Global Prize winner, cancer geneticist Steven Narod, MD, FRCPC, PhD (hon), FRSC, director of the Familial Breast Cancer Research Unit and a senior scientist at the Women’s College Hospital in Toronto, Ontario, Canada, discusses BRCA-related cancer research.

Men and women with BRCA gene mutations are at heightened risk for developing certain cancers, including breast, ovarian, prostate, and pancreatic cancers.